NASDAQ · DOX
Amdocs Limited financials
$57.59+0.30%
Close Sep 29, 2026 · split-adjustedRevenue
Net income
Income statement & cash flow
| Quarter | Q4 '23 Sep 30 | Q4 '22 Sep 30 | Q4 '21 Sep 30 | Q4 '20 Sep 30 | Q3 '20 Jun 30 | Q2 '20 Mar 31 | Q1 '20 Dec 31 | Q4 '19 Sep 30 | Q3 '19 Jun 30 | Q2 '19 Mar 31 | Q1 '19 Dec 31 | Q4 '18 Sep 30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | $1.05B | $1.03B | $1.05B | $1.04B | $1.03B | $1.02B | $1.02B | $1.01B | — |
| Gross profit | — | — | — | $349.4M | $344.5M | $364.0M | $355.6M | $363.1M | $359.8M | $361.0M | $349.5M | — |
| Gross margin | — | — | — | 33.2% | 33.6% | 34.7% | 34.1% | 35.2% | 35.1% | 35.4% | 34.5% | — |
| Operating income | — | — | — | $146.9M | $147.5M | $156.7M | $143.6M | $144.2M | $142.3M | $150.2M | $133.1M | — |
| Net income | — | — | — | $130.8M | $120.4M | $127.0M | $115.9M | $118.7M | $131.4M | $124.3M | $101.7M | — |
| Net margin | — | — | — | 12.4% | 11.7% | 12.1% | 11.1% | 11.5% | 12.8% | 12.2% | 10.0% | — |
| Diluted EPS | — | — | — | $1.01 | $0.90 | $0.94 | $0.85 | $0.89 | $0.96 | $0.90 | $0.72 | — |
| EBITDA | $0.00 | $0.00 | $0.00 | $146.9M | $194.1M | $205.8M | $192.6M | $144.2M | $195.7M | $200.6M | $184.6M | $0.00 |
| Operating cash flow | — | — | — | $204.7M | $186.7M | $102.9M | $163.9M | $213.6M | $164.5M | $168.6M | $109.7M | — |
| Free cash flow | — | — | — | — | $145.4M | $56.7M | $105.4M | — | $128.6M | $148.0M | $72.4M | — |
| Diluted shares | 118.5M | 121.9M | 128.0M | 133.2M | 133.6M | 135.1M | 135.6M | 137.2M | 137.1M | 138.7M | 140.5M | 142.6M |
Balance sheet
| Period end | Sep 30 | Sep 30 | Sep 30 | Sep 30 | Sep 30 | Sep 30 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $325.0M | $346.1M | $520.1M | $573.4M | $709.1M | $983.2M |
| Short-term investments | $0.00 | $168.2M | $222.5M | $244.6M | $256.5M | $752.0K |
| Total debt | $646.9M | $646.3M | $645.7M | $645.1M | $644.6M | $744.0M |
| Total assets | $6.25B | $6.39B | $6.43B | $6.39B | $6.51B | $6.34B |
| Total liabilities | $2.78B | $2.89B | $2.86B | $2.83B | $2.88B | $2.68B |
| Shareholders' equity | $3.47B | $3.50B | $3.57B | $3.56B | $3.64B | $3.67B |
From SEC filings via Massive. Fiscal periods follow the company's own calendar; free cash flow is operating cash flow minus capital expenditure.
Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology